Showing results (71-80 of 214) with videos related to
Sort By:
Pageof 22
Bioorganic & Medicinal Chemistry|January 5, 2010
Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogsCongde Huo, Huanjie Yang, Qiuzhi Cindy Cui, et al.Cancer Metastasis Reviews|October 18, 2017
Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agentsXin Chen, Qianqian Yang, Lu Xiao, et al.Biomarker Research|November 7, 2021
The role of ferroptosis in lung cancerSikai Wu, Chengchu Zhu, Daolin Tang, et al.Journal of Inorganic Biochemistry|January 24, 2014
Inhibition of the 26S proteasome as a possible mechanism for toxicity of heavy metal speciesDajena Tomco, Sara Schmitt, Mary Jane Heeg, et al.Tetrahedron|December 15, 2010
Synthesis of (2R, 3R)-epigallocatechin-3-O-(4-hydroxybenzoate), a novel catechin from Cistus salvifolius, and evaluation of its proteasome inhibitory activitiesKumi Osanai, Congde Huo, Kristin R Landis-Piwowar, et al.Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|October 8, 2009
Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cellsShumei Zhai, Lei Yang, Qiuzhi Cindy Cui, et al.Journal of Cellular Biochemistry|September 21, 2005
Differential effects of proteasome inhibitors on cell cycle and apoptotic pathways in human YT and Jurkat cellsMin Lu, Q Ping Dou, Richard P Kitson, et al.Biochemical Pharmacology|March 10, 2004
Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cellsKenyon G Daniel, Puja Gupta, R Hope Harbach, et al.International Journal of Molecular Medicine|July 3, 2010
Computational modeling of the potential interactions of the proteasome beta5 subunit and catechol-O-methyltransferase-resistant EGCG analogsJyoti Kanwar, Imthiyaz Mohammad, Huanjie Yang, et al.Plos One|January 7, 2014
Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasiaChiara Nardon, Sara M Schmitt, Huanjie Yang, et al.Pageof 22